Profile
Lori Friedman is currently Director at NextRNA Therapeutics, Inc. since 2023.
Director at Project Scientist since 2018.
Chief Scientific Officer at Oric Pharmaceuticals, Inc. since 2019.
Formerly Independent Director at Jiya Acquisition Corp.
Head-Translational Oncology at Genentech, Inc. Earned a doctorate from the University of California, Berkeley.
Lori Friedman active positions
| Companies | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Director/Board Member | 01/05/2018 |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Director/Board Member | 26/09/2023 |
Former positions of Lori Friedman
| Companies | Position | End |
|---|---|---|
| JIYA ACQUISITION CORP. | Director/Board Member | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Training of Lori Friedman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Miscellaneous |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
- Stock Market
- Insiders
- Lori Friedman
















